Results 61 to 70 of about 9,543 (166)

CD30 Expression in Neoplastic Mast Cells and the Presence of CD30+, CD3+, and PAX‐5+ Tumour‐Infiltrating Lymphocytes as Prognostic Markers in Canine Cutaneous Mast Cell Tumours

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 2, Page 341-352, June 2026.
ABSTRACT Canine cutaneous mast cell tumour (MCT) is the most common skin neoplasm in dogs, with histopathology serving as both the diagnostic and primary prognostic tool. However, identifying reliable biomarkers is essential for improving clinical decision‐making.
Fernanda Ramalho Ramos   +6 more
wiley   +1 more source

Characteristics and outcomes of patients with pediatric‐onset non‐mastocytosis mast cell activation disorders: A CEREMAST study

open access: yesPediatric Allergy and Immunology, Volume 37, Issue 5, May 2026.
Abstract Background Mast cell (MC) activation (MCA) disorders (MCAD) include diseases in which MCs excessively release mediators leading to recurrent manifestations of MCA. MCAD encompasses MCA syndrome (MCAS) which is defined by (i) documented systemic symptoms of MCA, (ii) a 20% increase in serum tryptase level from the individual's baseline plus 2 ...
M. Weiss   +25 more
wiley   +1 more source

Generalized Blistering in Infancy: A Rare Case Report on Bullous Mastocytosis

open access: yesNepal Journal of Dermatology, Venereology & Leprology
Mastocytosis is a rare myeloid neoplasm characterized by abnormal proliferation of mast cells, associated with c-KIT mutations. The disease is most frequently observed in childhood, with clinical presentations ranging from solitary mastocytoma to diffuse
Aditi Haldar   +3 more
doaj   +1 more source

Childhood Pseudoxanthomatousmastocytosis; Report of two cases

open access: yesIndian Journal of Dermatopathology and Diagnostic Dermatology, 2018
Cutaneous mastocytosis (CM) is a mast cell proliferative disorder that commonly affects pediatric population. It has various clinical forms such as urticaria pigmentosa, solitary mastocytoma, telangiectasia macularis eruptiva perstans, diffuse CM, and ...
Bhabani S. T. P. Singh   +3 more
doaj   +1 more source

Mastocytosis in Children: Literature Review and Own Clinical Observation

open access: yesZdorovʹe Rebenka, 2013
The review of literature presents the data on neoplastic disease — mastocytosis. We provide the modern information of the etiopathogenesis, classification, clinical presentation, methods of diagnosis and treatment in children. We presented own experience
N.V. Nagornaya   +3 more
doaj   +1 more source

Urticaria pigmentosa: A case report

open access: yesNepal Journal of Dermatology, Venereology & Leprology, 2016
Mastocytosis is a heterogenous group of diseases characterized by abnormal infiltration of mast cells in the skin and other organs. Urticaria Pigmentosa is the most common variant of cutaneous mastocytosis.
Mohammad Abid Keen
doaj   +3 more sources

Safety Practices During Hymenoptera Venom Immunotherapy: Single‐Centre Experience With Protocolised Intravenous Cannulation and Adrenaline Usage

open access: yes
Allergy, Volume 81, Issue 6, Page 2212-2214, June 2026.
Callum McWaters   +4 more
wiley   +1 more source

Cutaneous Mastocytosis in an Infant: Case Study

open access: yesВопросы современной педиатрии
Background. Cutaneous mastocytosis in children is a rare disease with benign outcome in most cases, however, its course can be aggravated by transformation into mast cell leukemia at the age over 10 years.
Artem A. Babkin   +2 more
doaj   +1 more source

Bullous mastocytosis: a Case Report

open access: yesJournal of the Egyptian Women’s Dermatologic Society
Mastocytosis is a disorder characterized by abnormal mast cell proliferation. The skin is the most common site of involvement. Extracutaneous involvement occurs in systemic mastocytosis with infiltrations in the gastrointestinal tract, lymph nodes, bone ...
Galal El Enany   +7 more
doaj   +1 more source

Disseminated tense bullae on newborn

open access: yesJAAD Case Reports, 2022
Graziele Áquila de Souza Brandão, MD   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy